Discounted Cash Flow (DCF) Analysis Levered
Standard BioTools Inc. (FLDM)
$3.71
-0.28 (-7.02%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 112.96 | 117.24 | 138.14 | 130.58 | 97.95 | 95.78 | 93.66 | 91.59 | 89.56 | 87.58 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | -25.20 | -35.21 | -15.42 | -44.06 | -89.37 | -36.11 | -35.31 | -34.53 | -33.76 | -33.02 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | -0.37 | -2.53 | -12.72 | -13.26 | -3.82 | -4.93 | -4.82 | -4.72 | -4.61 | -4.51 |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | -25.57 | -37.74 | -28.13 | -57.32 | -93.19 | -41.04 | -40.13 | -39.24 | -38.38 | -37.53 |
Weighted Average Cost Of Capital
| Share price | $ 3.71 |
|---|---|
| Beta | 1.138 |
| Diluted Shares Outstanding | 78.31 |
| Cost of Debt | |
| Tax Rate | 1.47 |
| After-tax Cost of Debt | 4.16% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 10.105 |
| Total Debt | 102.66 |
| Total Equity | 290.51 |
| Total Capital | 393.17 |
| Debt Weighting | 26.11 |
| Equity Weighting | 73.89 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Revenue | 112.96 | 117.24 | 138.14 | 130.58 | 97.95 | 95.78 | 93.66 | 91.59 | 89.56 | 87.58 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -25.20 | -35.21 | -15.42 | -44.06 | -89.37 | -36.11 | -35.31 | -34.53 | -33.76 | -33.02 |
| Capital Expenditure | -0.37 | -2.53 | -12.72 | -13.26 | -3.82 | -4.93 | -4.82 | -4.72 | -4.61 | -4.51 |
| Free Cash Flow | -25.57 | -37.74 | -28.13 | -57.32 | -93.19 | -41.04 | -40.13 | -39.24 | -38.38 | -37.53 |
| WACC | ||||||||||
| PV LFCF | -25.09 | -22.60 | -20.36 | -18.34 | -16.52 | |||||
| SUM PV LFCF | -155.09 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 8.55 |
| Free cash flow (t + 1) | -38.28 |
| Terminal Value | -584.39 |
| Present Value of Terminal Value | -387.75 |
Intrinsic Value
| Enterprise Value | -542.84 |
|---|---|
| Net Debt | 21.35 |
| Equity Value | -564.19 |
| Shares Outstanding | 78.31 |
| Equity Value Per Share | -7.21 |